Symphony Intrinsic Value
Symphony (SYMPHONY) median intrinsic value is ₹1197.30 from 4 valuation models (range ₹300–₹1497), vs current price ₹598.65 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. See SYMPHONY P/B ratio history to compare market price against book value per share.
SYMPHONY Valuation Methods Summary — DCF, Graham Number & P/E
Symphony intrinsic value across 4 models vs current price ₹598.65 — upside/downside and value range per method. For current market price and key ratios, visit Symphony stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹973.21 | ₹875.89 - ₹1070.53 | +62.6% | Book Value/Share: ₹389.29, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹1197.30 | ₹1077.57 - ₹1317.03 | +100.0% | Revenue/Share: ₹1002.86, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹1496.62 | ₹1197.30 - ₹1795.94 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹300.00 | ₹270.00 - ₹330.00 | -49.9% | DPS: ₹9.00, Target Yield: 3.0% |
SYMPHONY Intrinsic Value vs Market Price — All Valuation Models
Symphony fair value range ₹300–₹1497 vs current market price ₹598.65 across 4 valuation models. Check SYMPHONY market value to track the company's total market size over time.
SYMPHONY Intrinsic Value Analysis — Undervalued or Overvalued?
Symphony median intrinsic value ₹1197.30, current price ₹598.65 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of SYMPHONY?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Symphony (SYMPHONY) is ₹1197.30 (median value). With the current market price of ₹598.65, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹300.00 to ₹1496.62, indicating ₹300.00 - ₹1496.62.
Is SYMPHONY undervalued or overvalued?
Based on our multi-method analysis, Symphony (SYMPHONY) appears to be trading below calculated value by approximately 100.0%.
SYMPHONY Financial Health — Key Ratios vs Industry Benchmarks
Symphony financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 23.03 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -160.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -47.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.36x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SYMPHONY Cash Flow Quality — Operating & Free Cash Flow
Symphony operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-81 Cr | ₹-81 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹259 Cr | ₹239 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹162 Cr | ₹162 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹125 Cr | ₹119 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹57 Cr | ₹57 Cr | Positive Free Cash Flow | 8/10 |